Literature DB >> 28072697

Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians.

Kazuyoshi Suenari1, Tze-Fan Chao, Chia-Jen Liu, Yasuki Kihara, Tzeng-Ji Chen, Shih-Ann Chen.   

Abstract

The HATCH score (hypertension <1 point>, age >75 years <1 point>, stroke or transient ischemic attack <2 points>, chronic obstructive pulmonary disease <1 point>, and heart failure <2 points>) was reported to be useful for predicting the progression of atrial fibrillation (AF) from paroxysmal to persistent or permanent AF for patients who participated in the Euro Heart Survey. The goal of the current study was to investigate whether the HATCH score was a useful scheme in predicting new-onset AF. Furthermore, we aimed to use the HATCH scoring system to estimate the individual risk in developing AF for patients with different comorbidities. We used the "Taiwan National Health Insurance Research Database." From January 1, 2000, to December 31, 2001, a total of 670,804 patients older than 20 years old and who had no history of cardiac arrhythmias were enrolled. According to the calculation rule of the HATCH score, 599,780 (score 0), 46,661 (score 1), 12,892 (score 2), 7456 (score 3), 2944 (score 4), 802 (score 5), 202 (score 6), and 67 (score 7) patients were studied and followed for the new onset of AF. During a follow-up of 9.0 ± 2.2 years, there were 9174 (1.4%) patients experiencing new-onset AF. The incidence of AF was 1.5 per 1000 patient-years. The incidence increased from 0.8 per 1000 patient-years for patients with a HATCH score of 0 to 57.3 per 1000 patient-years for those with a HATCH score of 7. After an adjustment for the gender and comorbidities, the hazard ratio (95% confidence interval) of each increment of the HATCH score in predicting AF was 2.059 (2.027-2.093; P < 0.001). The HATCH score was useful in risk estimation and stratification of new-onset AF.

Entities:  

Mesh:

Year:  2017        PMID: 28072697      PMCID: PMC5228657          DOI: 10.1097/MD.0000000000005597

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Atrial fibrillation (AF) is an important risk factor for the ischemic stroke, and the AF-related stroke has a worse prognosis and a higher recurrence rate compared with the non-AF-related stroke.[ It has been believed that AF was revealed as a paroxysmal state and then became sustained as a persistent state.[ Recently, de Vos et al[ reported the useful predicting factors of progression from paroxysmal to persistent as a HATCH score (hypertension <1 point>, age >75 years <1 point>, transient ischemic attack [TIA] or stroke <2 points>, chronic obstructive pulmonary disease [COPD] <1 point>, and heart failure <2 points>) in AF patients who participated in the Euro Heart Survey. The progressive mechanism is considered due to the electrical and structural remodeling of the atria based on those risk factors. However, the scoring system for predicting the new-onset of AF has not been well established. Since the risk factors of new-onset of AF could be close to the progression of AF from paroxysmal to persistent, we investigated whether the HATCH score was a useful scheme in predicting new-onset of AF using a large cohort in Taiwan. Furthermore, we aimed to use the HATCH scoring system to estimate the individual risk in developing AF for patients with different comorbidities.

Methods

The study design and methodology of the present study are similar to our previous studies.[ This retrospective study used the National Health Insurance Research Database (NHIRD) of the Taiwan National Health Research Institutes. The National Health Insurance (NHI) system is a mandatory universal health insurance program that offers comprehensive medical care coverage to all Taiwanese residents. The NHIRD was a cohort dataset which contained all the medical claims data for 1,000,000 beneficiaries, who were randomly sampled from the 23 million enrollees under the NHI program. In this cohort dataset, the patients’ original identification numbers have been encrypted to protect their privacy, but the encrypting procedure was consistent, so that a linkage of the claims belonging to the same patient was feasible within the NHI database and can be followed continuously. The large database provided a good opportunity to study the usefulness of the HATCH score in predicting new-onset AF. The HATCH score was calculated for each patient based on a point system (2 points for either a history of TIA/stroke or heart failure, respectively; 1 point for hypertension, age >75 years, or COPD, respectively). Information about important comorbid conditions of each individual was retrieved from the medical claims based on the International Classification of Diseases-Ninth Revision-Clinical Modification (ICD-9-CM) codes. We defined patients with a certain disease only when it was a discharge diagnosis or confirmed more than twice in an outpatient department. The diagnostic accuracies of important comorbidities in Taiwan NHIRD, such as hypertension, diabetes mellitus, heart failure, myocardial infarction, hyperlipidemia, and chronic obstructive pulmonary disease, have been validated before.[

Study cohort and clinical endpoint

From January 1, 2000, to December 31, 2011, a total of 670,804 patients older than 20 years and who had no history of cardiac arrhythmias were identified from the Taiwan NHIRD. The HATCH score was calculated for every patient. Finally, 599,780 (score 0), 46,661 (score 1), 12,892 (score 2), 7456 (score 3), 2944 (score 4), 802 (score 5), 202 (score 6), and 67 (score 7) patients were studied and followed for the occurrences of AF. A flowchart of the study enrollment is shown in Fig. 1.
Figure 1

The flowchart of the enrollment of the study patients.

The flowchart of the enrollment of the study patients. The clinical endpoint was the occurrence of new-onset AF (ICD-9-CM code 427.31) during the follow-up period. To ensure the accuracy of diagnosis, we defined patients as having AF only when it was a discharge diagnosis or confirmed more than twice in the outpatient department.[ The diagnostic accuracy of AF using definition in NHIRD has been validated previously.[

Statistical analysis

Data were presented as the mean ± SD for continuous variables and proportions for categorical variables. An unpaired 2-tailed Student's t test was used for the analysis of continuous variables, and the differences between nominal variables were compared by the chi-square test. The incidence rate of new-onset of AF was calculated by dividing the number of events by person-time at risk with the 95% confidence interval (CI) estimated by exact binomial probabilities. The risk of incidence of AF was assessed using the Cox regression analysis. Statistical significance was set at P<0.05, and all statistical analyses were carried out by using SPSS 17.0 (SPSS, Chicago, IL). The present study was approved by the Institutional Review Board (IRB) at Taipei Veterans General Hospital, Taipei, Taiwan.

Results

The age, percentage of each risk factor, and HATCH score of the study patients are shown in Table 1. The mean ages were 42.4 ± 16.0 years, and most of the patients (89.4%) have a HATCH score 0.
Table 1

Baseline characteristics of the patients (n = 670,804).

Baseline characteristics of the patients (n = 670,804). During a follow-up of 9.0 ± 2.2 years, there were 9174 (1.4%) patients experiencing new-onset AF. The overall incidence of AF was 1.5 per 1000 patient-years. The incidence rate increased from 0.8 per 1000 patient-years for patients with a HATCH score of 0 to 57.3 per 1000 patient-years for those with a HATCH score of 7 (Table 2 and Fig. 2).
Table 2

Incidence of new-onset AF in patients with different HATCH scores.

Figure 2

Incidence of new-onset AF in patients with different HATCH scores. AF = atrial fibrillation.

Incidence of new-onset AF in patients with different HATCH scores. Incidence of new-onset AF in patients with different HATCH scores. AF = atrial fibrillation. Figure 3 shows that the cumulative incidence curves of AF for patients with different HATCH scores. It demonstrated that patients with higher HATCH scores were associated with a higher rate of new-onset AF during the follow-up period. After an adjustment for the gender and comorbidities other than the components of the HATCH scoring system (diabetes mellitus, coronary artery disease, end-stage renal disease, and malignancy) in the multivariate regression analysis, the hazard ratio (95% confidence interval) of each increment of the HATCH score in predicting AF was 2.059 (2.027–2.093; P <0.001). The relative risk of the development of AF in each group of patients with different HATCH scores compared to those with a HATCH score of 0 represented by hazard ratios is shown in Table 3 and Fig. 4. The c-index on the basis of area under the receiver operating characteristic curve for the HATCH score in predicting new-onset AF was 0.716 (95% confidence interval = 0.710–0.723, P value < 0.001).
Figure 3

The cumulative incidence curves with a log-rank test demonstrated that patients with higher HATCH scores were associated with a higher rate of new-onset AF during the follow-up period. AF = atrial fibrillation.

Table 3

Hazard ratio of new onset AF in patients with different HATCH scores in comparison to the patients with a HATCH score of zero.

Figure 4

Risk of new-onset AF in patients with different HATCH scores. AF = atrial fibrillation.

The cumulative incidence curves with a log-rank test demonstrated that patients with higher HATCH scores were associated with a higher rate of new-onset AF during the follow-up period. AF = atrial fibrillation. Hazard ratio of new onset AF in patients with different HATCH scores in comparison to the patients with a HATCH score of zero. Risk of new-onset AF in patients with different HATCH scores. AF = atrial fibrillation.

Discussion

The present study is the first large-scale nationwide population-based investigation analyzing the risk of new-onset of AF stratified by the HATCH score. We demonstrated that the overall incidence rate of AF was 1.5 per 1000 patient-years in Taiwan, and the HATCH score could be used to estimate the individual risk of new-onset AF for patients with different comorbidities.

HATCH score and risk of incident AF

It is well known that an abnormally rapid firing from the pulmonary veins can trigger and initiate AF.[ Moreover, an arrhythmogenic atrial substrate could be related to AF maintenance rotor with the generation of wave splitting and stabilized re-entry.[ The AF substrate can result from the electrical and structural remodeling due to an aging effect and several systemic diseases such as hypertension and heart failure.[ Therefore, AF might easily occur and become perpetuated without self-termination to SR among patients having a high HATCH score. COPD, a pulmonary rather than cardiovascular disorder, represents a unique component of the HATCH scheme. AF and COPD frequently coexist and complicate treatment of both conditions. Previous researches reported that COPD had been present in more than one-tenth of the patients with AF and were associated with increased mortality and incidence of major adverse events.[ Recent studies have demonstrated that reduced forced expiratory volume in 1 second (FEV1) and obstructive respiratory disease were associated with an increased risk of incident AF.[ Li et al[ analyzed the data of 15,004 middle-aged subjects enrolled in the Atherosclerosis Risk in Communities (ARIC) cohort study; the rate of incident AF was inversely associated with FEV1. There were several possible mechanisms which may explain for the relationship between COPD and AF. Impaired lung function could trigger ectopic beats by deterioration of gas composition and pulmonary hypertension,[ resulting in elevated atrial pressure and altering the electrophysiological properties of atrial tissues, which in turn trigger AF.[ Besides, hypercapnia, which was not uncommon in COPD patients, could alter atrial electrophysiology and increase the vulnerability to AF.[

Clinical applications

Although the reported incidence and prevalence of AF is lower in Asians than Caucasians,[ Asia has a higher overall disease burden because of its proportionally larger aged population.[ For example, on the basis of reported age-adjusted prevalence rates and projected population figures in China, there will be an estimated 5.2 million men and 3.1 million women with AF older than 60 years by year 2050.[ Therefore, how to estimate the risk of incidental AF among Asians is an important issue. There were several scoring schemes which have been proposed to predict the risk of new-onset AF.[ However, the data from which these clinical risk stratification schemes derive were acquired in cohorts, which mainly consisted of Caucasian patients, such as ARIC and Framingham Heart Studies. In the present study, we showed that an easily calculated clinical scheme, the HATCH score, can be used to estimate the individual risk of incidental AF for patients with different comorbidities. As contrasted with the HATCH score, both of CHADS2 and CHA2DS2-VASc scores include a diabetes mellitus (DM).[ Several studies show that type 2 DM could play an important role of AF induction and maintenance[ and lead to cerebrovascular complications due to even brief episodes of AF.[ Moreover, patients with chronic heart failure (CHF) are also reported to have a potential of having subclinical AF.[ Therefore, DM and CHF patients with cryptogenic stroke and transient ischemic attack who showed high risk of new onset of AF based on the HATCH score should be strongly considered to implant a continuous monitoring device for detecting subclinical AF. The c-index on the basis of area under the receiver operating characteristic curve of HATCH score in predicting new-onset AF (0.716) was similar to, but slightly higher than that of, the CHADS2 score (c-index = 0.713) reported in the previous publication.[ Furthermore, when patients having a high HATCH score without previously documented AF exhibit acute stroke, we may have to survey for “subclinical” AF more aggressively to reduce the risk of recurrent ischemic events through the use of oral anticoagulants.

Study limitations

There were several limitations of the present study. First, the diagnosis of AF was based on the diagnostic codes registered by the physicians responsible for the treatments of patients, and was not further checked externally. However, the accuracy of diagnosis of AF in Taiwan's NHIRD has been previously well validated.[ Second, the present study only enrolled Taiwanese patients, and whether the results can be extrapolated to other populations remains uncertain. A further prospective study is necessary to confirm the results of our study.

Conclusions

The HATCH score which consisted of an age >75 and several clinical risk factors was useful for the risk estimation and stratification of the development of AF.
  39 in total

1.  Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose.

Authors:  Tze-Fan Chao; Kazuyoshi Suenari; Shih-Lin Chang; Yenn-Jiang Lin; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Ching-Tai Tai; Hsuan-Ming Tsao; Cheng-Hung Li; Kuo-Chang Ueng; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Am J Cardiol       Date:  2010-10-14       Impact factor: 2.778

2.  Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation.

Authors:  S A Chen; M H Hsieh; C T Tai; C F Tsai; V S Prakash; W C Yu; T L Hsu; Y A Ding; M S Chang
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

3.  Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan.

Authors:  Ching-Lan Cheng; Yea-Huei Yang Kao; Swu-Jane Lin; Cheng-Han Lee; Ming Liang Lai
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-12-29       Impact factor: 2.890

4.  Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.

Authors:  Tze-Fan Chao; Chia-Jen Liu; Jo-Nan Liao; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Fa-Po Chung; Tzeng-Ji Chen; Gregory Y H Lip; Shih-Ann Chen
Journal:  Circulation       Date:  2016-03-11       Impact factor: 29.690

Review 5.  Pulmonary hypertension in patients with interstitial lung diseases.

Authors:  Jay H Ryu; Michael J Krowka; Patricia A Pellikka; Karen L Swanson; Michael D McGoon
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

Review 6.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century.

Authors:  Jocasta Ball; Melinda J Carrington; John J V McMurray; Simon Stewart
Journal:  Int J Cardiol       Date:  2013-02-04       Impact factor: 4.164

7.  Stroke severity in atrial fibrillation. The Framingham Study.

Authors:  H J Lin; P A Wolf; M Kelly-Hayes; A S Beiser; C S Kase; E J Benjamin; R B D'Agostino
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

8.  CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan.

Authors:  Tze-Fan Chao; Chia-Jen Liu; Su-Jung Chen; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Tsu-Juey Wu; Tzeng-Ji Chen; Shih-Ann Chen
Journal:  Int J Cardiol       Date:  2012-12-29       Impact factor: 4.164

9.  Novel assessment of temporal variation in fractionated electrograms using histogram analysis of local fractionation interval in patients with persistent atrial fibrillation.

Authors:  Yenn-Jiang Lin; Kazuyoshi Suenari; Men-Tzung Lo; Chen Lin; Wan-Hsin Hsieh; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Chen-Chuan Cheng; Yasuki Kihara; Tze-Fan Chao; Beny Hartono; Tsu-Juey Wu; Wei-Shiang Lin; Ke-Hsin Hsu; Ambrose S Kibos; Norden E Huang; Shih-Ann Chen
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-07-25

10.  Airflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Jingjing Li; Sunil K Agarwal; Alvaro Alonso; Saul Blecker; Alanna M Chamberlain; Stephanie J London; Laura R Loehr; Ann Marie McNeill; Charles Poole; Elsayed Z Soliman; Gerardo Heiss
Journal:  Circulation       Date:  2013-12-16       Impact factor: 29.690

View more
  18 in total

1.  Risk-Based Disease Surveillance: The Promise of Early Atrial Fibrillation Identification.

Authors:  Marcie G Berger; David Gutterman
Journal:  Chest       Date:  2019-03       Impact factor: 9.410

2.  Risk factors for recurrence of atrial fibrillation.

Authors:  Antoniya Kisheva; Yoto Yotov
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

3.  Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores.

Authors:  Jingjing Han; Guangling Li; Demei Zhang; Xiaomei Wang; Xueya Guo
Journal:  Front Cardiovasc Med       Date:  2022-06-21

4.  A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.

Authors:  Yan-Guang Li; Daniele Pastori; Alessio Farcomeni; Pil-Sung Yang; Eunsun Jang; Boyoung Joung; Yu-Tang Wang; Yu-Tao Guo; Gregory Y H Lip
Journal:  Chest       Date:  2018-10-04       Impact factor: 9.410

5.  Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study.

Authors:  Mariana Alves; Ana Mafalda Abrantes; Gonçalo Portugal; M Manuela Cruz; Sofia Reimão; Daniel Caldeira; José M Ferro; Joaquim J Ferreira
Journal:  Front Neurol       Date:  2021-05-12       Impact factor: 4.003

6.  Validation of Risk Scores for Predicting Atrial Fibrillation Detected After Stroke Based on an Electronic Medical Record Algorithm: A Registry-Claims-Electronic Medical Record Linked Data Study.

Authors:  Cheng-Yang Hsieh; Hsuan-Min Kao; Kuan-Lin Sung; Luciano A Sposato; Sheng-Feng Sung; Swu-Jane Lin
Journal:  Front Cardiovasc Med       Date:  2022-04-29

7.  What is next for screening for undiagnosed atrial fibrillation? Artificial intelligence may hold the key.

Authors:  Ramesh Nadarajah; Jianhua Wu; Alejandro F Frangi; David Hogg; Campbell Cowan; Chris P Gale
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-06-06

8.  Predictive Value of HATCH Scoring and Waist-to-Height Ratio in Atrial Fibrillation Following Coronary Artery Bypass Operations Performed with Cardiopulmonary Bypass.

Authors:  Muhammed Savran; Mesut Engin; Orhan Guvenc; Hasan F Yüksek; Sadık Ahmet Sünbül; Tamer Turk; Yusuf Ata; Ufuk Aydın; Ahmet F Ozyazicioglu
Journal:  J Saudi Heart Assoc       Date:  2021-02-10

9.  Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.

Authors:  Ramesh Nadarajah; Eman Alsaeed; Ben Hurdus; Suleman Aktaa; David Hogg; Matthew G D Bates; Campbel Cowan; Jianhua Wu; Chris P Gale
Journal:  Heart       Date:  2022-06-10       Impact factor: 7.365

Review 10.  Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Authors:  Hai Deng; Ying Bai; Alena Shantsila; Laurent Fauchier; Tatjana S Potpara; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2017-05-30       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.